UMN Pharma, Daiichi Sankyo deal

UMN partnered with Daiichi to develop a norovirus vaccine. UMN will exclusively provide Daiichi with recombinant norovirus virus-like particle (VLP) antigen produced by a cell-culture manufacturing me...